What Happened to DermTech?
Ticker: DMTKQSPAC Year: 2017Merger: 2018
Return
0.0%
Current Price
$0
Peak Price
â
Trust Size
$103M
Summary
DermTech was a precision dermatology company that developed non-invasive skin genomics technology for melanoma detection, eliminating the need for surgical biopsies. The company went public via SPAC merger with Constellation Alpha Capital Corp in 2019. It filed for Chapter 11 bankruptcy in June 2024.
What Happened
Constellation Alpha Capital Corp merged with DermTech in 2019. The company's non-invasive skin cancer test showed promise but struggled with reimbursement and commercialization. DermTech filed for Chapter 11 in June 2024, laid off 20% of staff, and sought a buyer for its technology. The company was renamed DTech Liquidating Inc as assets were sold off.
Timeline
2017-06-14
S-1 Registration Filed
2018-08-23
Merger Proxy Filed (DEFM14A)
2024-07-19
Last SEC Filing